Total Raised

$121.52M

Investors Count

3

Funding, Valuation & Revenue

13 Fundings

Aerami Therapeutics has raised $121.52M over 13 rounds.

Aerami Therapeutics's latest funding round was a Dead for on August 30, 2024.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/30/2024

Dead

Dead

$XXM

0

FY undefined

1

11/22/2023

Debt

$1.02M

Undisclosed Investors

$XXM

0

FY undefined

1

12/16/2022

Unattributed VC - VIII

$5.38M

$XXM

0

FY undefined

1

9/23/2021

Unattributed VC - VII

$XXM

$XXM

0

FY undefined

10

6/17/2020

Unattributed VC - VI

$XXM

$XXM

0

FY undefined

10

Date

8/30/2024

11/22/2023

12/16/2022

9/23/2021

6/17/2020

Round

Dead

Debt

Unattributed VC - VIII

Unattributed VC - VII

Unattributed VC - VI

Amount

$1.02M

$5.38M

$XXM

$XXM

Investors

Dead

Undisclosed Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

1

1

10

10

Start free trial
New call-to-action

Aerami Therapeutics Investors

3 Investors

Aerami Therapeutics has 3 investors. SternAegis Ventures invested in Aerami Therapeutics's Unattributed VC - VIII funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/26/2017

12/16/2022

8
Unattributed VC, Unattributed VC - II (2017), Unattributed VC - III (2018), Unattributed VC - IV (2018), Unattributed VC - V (2019), Unattributed VC - VI (2020), Unattributed VC - VII (2021), Unattributed VC - VIII (2022)

Corporate Venture

New York

00/00/0000

00/00/0000

Forte Ventures

Subscribe to see more

Venture Capital

Georgia

00/00/0000

00/00/0000

Molex Ventures

Subscribe to see more

Venture Capital

United States

First funding

4/26/2017

00/00/0000

00/00/0000

Last Funding

12/16/2022

00/00/0000

00/00/0000

Investor

Forte Ventures

Molex Ventures

Rounds

8
Unattributed VC, Unattributed VC - II (2017), Unattributed VC - III (2018), Unattributed VC - IV (2018), Unattributed VC - V (2019), Unattributed VC - VI (2020), Unattributed VC - VII (2021), Unattributed VC - VIII (2022)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Venture Capital

Location

New York

Georgia

United States

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.